Phase II studies of docetaxel in the treatment of various solid tumours
Jaco J. Verweij(Elisabeth-TweeSteden Ziekenhuis), Q. van Hoesel(Radboud University Nijmegen), Cora N. Sternberg(Cornell University), Steinar Aamdal(Humboldt-Universität zu Berlin), Ingmar Wolff(Universitätsmedizin Greifswald), G. Catimel(Centre Léon Bérard), Aarón Sulkes
Cited by 31
Related Papers
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
|The Lancet|2002|1.7k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k
Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
|New England Journal of Medicine|1997|1.6k